Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes.

Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes.

PLoS One. 2018;13(3):e0195230

Authors: Lyu AR, Kim DH, Lee SH, Shin DS, Shin SA, Park YH

Abstract
Preservation of residual hearing after cochlear implant is an important issue with regards to hearing performance. Various methods of steroid administration have been widely used in clinical practice to reduce inflammation and preserve residual hearing. Here we compare the effect of different routes of dexamethasone administration on intracochlear inflammation and residual hearing in guinea pig ears. Dexamethasone was delivered into the guinea pigs either through intracochlear, intratympanic or systemic route. The intracochlear concentration of dexamethasone, residual hearing, inflammatory cytokines and histopathologic changes were evaluated over time. A higher intracochlear dexamethasone concentration was observed after intracochlear administration than through the other routes. Residual hearing was better preserved with local dexamethasone administration as was supported by the reduced inflammatory cytokines, more hair cell survival and less severe intracochlear fibrosis and ossification concurrently seen in the local delivery group than in the systemic group. The results demonstrate that local dexamethasone delivery can reduce intracochlear inflammation and preserve residual hearing better than in systemically administered dexamethasone.

PMID: 29601595 [PubMed - in process]

https://ift.tt/2GYISpB